Stock News

U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy
US Government Calls For Additional Eli Lilly COVID-19 Antibody Therapy
What's Moving The Market Friday? US Stocks Near Flat, Euro, Asian Stocks Lower
UPDATE 2-U.S. to buy at least 100,000 doses of Lilly's COVID-19 antibody therapy
Eli Lilly says U.S. government has agreed to buy at least 100,000 doses of its COVID antibody therapy
Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19
Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly's connected insulin solutions
Alvogen Pharma US, Inc. -- Moody's affirms Alvogen's ratings; outlook revised to negative
Lilly to Participate in Cowen Health Care Conference
Top 15 Pharmaceutical Companies With Highest R&D Spending
Eli Lilly Is Poised for a Pullback Before Renewed Longer-Term Gains
3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
Why Rigel Pharmaceuticals Stock Is Jumping Today
Return On Capital Employed Overview: Eli Lilly

As seen on...